Jasper Therapeutics Inc Total Liabilities

Latest as of June 2026: $10.39 Million USD

Jasper Therapeutics Inc total liabilities. Based on the latest financial reports, Jasper Therapeutics Inc (JSPR) has total liabilities worth $10.39 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Jasper Therapeutics Inc to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Jasper Therapeutics Inc (2019–2025)

Total liabilities of Jasper Therapeutics Inc from 2019 to 2025. This chart illustrates how Jasper Therapeutics Inc's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Jasper Therapeutics Inc to see how much of total assets are deployed in long-term investments.

Jasper Therapeutics Inc Competitors by Total Liabilities

The table below lists competitors of Jasper Therapeutics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
UMS-Neiken Group Bhd KLSE:7227	Malaysia	RM8.43 Million
Fuji Finance Indonesia Tbk PT JK:FUJI	Indonesia	Rp8.65 Billion
Century Casinos Inc NASDAQ:CNTY	USA	$1.14 Billion
Deltamac Taiwan Co Ltd TWO:6144	Taiwan	NT$53.16 Million
Dorsavi Ltd AU:DVL	Australia	AU$1.14 Million
Shradha Infraprojects Limited NSE:SHRADHA	India	Rs1.52 Billion
ATP 30 Public Company Limited BK:ATP30	Thailand	฿667.54 Million
Microba Life Sciences Ltd AU:MAP	Australia	AU$12.27 Million

Liability Composition Analysis (2019–2025)

This chart breaks down Jasper Therapeutics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Jasper Therapeutics Inc assets under control.

Liquidity & Leverage Metrics

Jasper Therapeutics Inc Total Liabilities Ratios Explained

Jasper Therapeutics Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.47	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	7.35	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.88	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jasper Therapeutics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jasper Therapeutics Inc (2019–2025)

The table below shows the annual total liabilities of Jasper Therapeutics Inc from 2019 to 2025.

Year	Total Liabilities	Change
2025-12-31	$31.63 Million	+73.54%
2024-12-31	$18.23 Million	+10.78%
2023-12-31	$16.45 Million	+32.98%
2022-12-31	$12.37 Million	-48.74%
2021-12-31	$24.14 Million	-58.73%
2020-12-31	$58.49 Million	+857.39%
2019-12-31	$6.11 Million	--

About Jasper Therapeutics Inc

NASDAQ:JSPR USA Biotechnology

Market Cap

$15.97 Million

Market Cap Rank

#25632 Global

#5413 in USA

Share Price

$0.48

Change (1 day)

-5.51%

52-Week Range

$0.34 - $2.05

All Time High

$164.20